SCHEMBL7413841

SCHEMBL7413841

FC(F)(Br)C#Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.52
▸ MAPT P10636 3/20 0.41
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ THPO P40225 1/20 0.39
▸ BLM P54132 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MTOR P42345 1/20 0.37
▸ RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL562862 0.82 APP (0.55) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL16439860 0.78 APP (0.50) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL28579920 0.75 APP (0.46) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL8728188 0.73 MAPT (0.47) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL28600443 0.73 APP (0.44) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL2183993 0.72 APP (0.55) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL562815 0.72 APP (0.55) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL28577550 0.72 APP (0.42) APPMAPTCYP1A2CYP3A4CYP2C9
SCHEMBL9794436 0.72 MAPT (0.50) APPMAPTNPC1ALDH1A1KMT2A
SCHEMBL28584050 0.72 APP (0.42) APPMAPTCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5256677-A Enzyme inhibitor for treating acquired immune deficiency syndrome ABBOTT LABORATORIES (US) 1993-10-26 — — US disclosed
WO-1992017176-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1992-10-15 — — WO disclosed
US-5151438-A Enzyme inhibitors for treatment of aids ABBOTT LABORATORIES (US) 1992-09-29 — — US disclosed
Send feedback